Los Angeles-based ultrasound AI developer iCardio.ai has received a $1 million prize from the Roddenberry Foundation.
The Roddenberry Prize supports groundbreaking ventures that have the potential to profoundly impact the world and would allow more people to "live long and prosper," according to the Roddenberry Foundation.
“Star Trek creator Gene Roddenberry envisioned a future where heart disease is a thing of the past. Now, his family is funding what may become a real-life version of the Star Trek tricorder,” the foundation said in a news release.
iCardio.ai’s technology includes a suite of cardiac ultrasound AI tools for use with handheld, whole-body point-of-care ultrasound probes. The tools automate key echocardiographic measurements of the heart that can help detect valvular diseases, like aortic stenosis, and provide image quality assessments.
The award will enable iCardio.ai to scale its technology to reach more people, particularly those in regions where cardiovascular care is lacking, the company said.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
